286 related articles for article (PubMed ID: 27452673)
1. Small-molecule binding sites to explore protein-protein interactions in the cancer proteome.
Xu D; Jalal SI; Sledge GW; Meroueh SO
Mol Biosyst; 2016 Oct; 12(10):3067-87. PubMed ID: 27452673
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces.
Engin HB; Kreisberg JF; Carter H
PLoS One; 2016; 11(4):e0152929. PubMed ID: 27043210
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites.
Kumar AP; Nguyen MN; Verma C; Lukman S
Proteins; 2018 Mar; 86(3):301-321. PubMed ID: 29235148
[TBL] [Abstract][Full Text] [Related]
4. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
[TBL] [Abstract][Full Text] [Related]
5. A historical overview of protein kinases and their targeted small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
[TBL] [Abstract][Full Text] [Related]
6. Structural conservation of druggable hot spots in protein-protein interfaces.
Kozakov D; Hall DR; Chuang GY; Cencic R; Brenke R; Grove LE; Beglov D; Pelletier J; Whitty A; Vajda S
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13528-33. PubMed ID: 21808046
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive assessment of cancer missense mutation clustering in protein structures.
Kamburov A; Lawrence MS; Polak P; Leshchiner I; Lage K; Golub TR; Lander ES; Getz G
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):E5486-95. PubMed ID: 26392535
[TBL] [Abstract][Full Text] [Related]
8. Systematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A).
Dadgar S; Floriano WB
Mol Cell Probes; 2015 Jun; 29(3):135-43. PubMed ID: 25745992
[TBL] [Abstract][Full Text] [Related]
9. Detection of secondary binding sites in proteins using fragment screening.
Ludlow RF; Verdonk ML; Saini HK; Tickle IJ; Jhoti H
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15910-5. PubMed ID: 26655740
[TBL] [Abstract][Full Text] [Related]
10. Discovering Innovative Drugs Targeting Both Cancer and Cardiovascular Disease by Shared Protein-Protein Interaction Network Analyses.
Tiwari S; Dwivedi UN
OMICS; 2019 Sep; 23(9):417-425. PubMed ID: 31329050
[TBL] [Abstract][Full Text] [Related]
11. Photoaffinity Labeling of Pentameric Ligand-Gated Ion Channels: A Proteomic Approach to Identify Allosteric Modulator Binding Sites.
Jayakar SS; Ang G; Chiara DC; Hamouda AK
Methods Mol Biol; 2017; 1598():157-197. PubMed ID: 28508361
[TBL] [Abstract][Full Text] [Related]
12. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in the development of protein-protein interaction inhibitors targeting androgen receptor-coactivator binding in prostate cancer.
Biron E; Bédard F
J Steroid Biochem Mol Biol; 2016 Jul; 161():36-44. PubMed ID: 26196120
[TBL] [Abstract][Full Text] [Related]
14. Exhaustive Repertoire of Druggable Cavities at Protein-Protein Interfaces of Known Three-Dimensional Structure.
Da Silva F; Bret G; Teixeira L; Gonzalez CF; Rognan D
J Med Chem; 2019 Nov; 62(21):9732-9742. PubMed ID: 31603323
[TBL] [Abstract][Full Text] [Related]
15. Allosteric Modulators of Protein-Protein Interactions (PPIs).
Ni D; Liu N; Sheng C
Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.
Catrow JL; Zhang Y; Zhang M; Ji H
J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283
[TBL] [Abstract][Full Text] [Related]
17. Domain-based small molecule binding site annotation.
Snyder KA; Feldman HJ; Dumontier M; Salama JJ; Hogue CW
BMC Bioinformatics; 2006 Mar; 7():152. PubMed ID: 16545112
[TBL] [Abstract][Full Text] [Related]
18. MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
Harati S; Cooper LA; Moran JD; Giuste FO; Du Y; Ivanov AA; Johns MA; Khuri FR; Fu H; Moreno CS
PLoS One; 2017; 12(1):e0170339. PubMed ID: 28118365
[TBL] [Abstract][Full Text] [Related]
19. Discovery of short linear motif-mediated interactions through phage display of intrinsically disordered regions of the human proteome.
Davey NE; Seo MH; Yadav VK; Jeon J; Nim S; Krystkowiak I; Blikstad C; Dong D; Markova N; Kim PM; Ivarsson Y
FEBS J; 2017 Feb; 284(3):485-498. PubMed ID: 28002650
[TBL] [Abstract][Full Text] [Related]
20. Predicting Protein-Protein Interactions from the Molecular to the Proteome Level.
Keskin O; Tuncbag N; Gursoy A
Chem Rev; 2016 Apr; 116(8):4884-909. PubMed ID: 27074302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
